In regard to the screening strategy among patients with chronic renal disease (CRD), both the American Thoracic Society35 and American Transplant Society36 guidelines recommend that all immunocompromised subjects and transplant candidates be screened for TB with a tuberculin skin test (TST) or IFN-γ releasing assay (IGRA). Here, IFNG is linked to chronic kidney disease.